Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 297.00
Bid: 290.00
Ask: 304.00
Change: 0.00 (0.00%)
Spread: 14.00 (4.828%)
Open: 297.00
High: 297.00
Low: 297.00
Prev. Close: 297.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Jan 2020 17:11

RNS Number : 6469A
MaxCyte, Inc.
22 January 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

 

Maxcyte Inc

54930053YHXULRFCU991

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

 

Legal & General Group Plc (Group)

 

Legal & General (Unit Trust Managers) Limited

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

4. Full name of shareholder(s) (if different from 3.)v

Name

 

Legal & General Assurance Society (LGAS)

 

Legal & General Assurance

(Pensions Management) Limited (PMC)

 

City and country of registered office (if applicable)

1 Coleman St, London EC2R 5AA

5. Date on which the threshold was crossed or reachedvi:

 

20 January 2020

 

6. Date on which issuer notified (DD/MM/YYYY):

 

22 January 2020

 

 

 

 

 

 

 

 

 

7. Total positions of person(s) subject to the notification obligation

 

 

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

Below 5%

-

Below 5%

57,403,583

Position of previous notification (if

applicable)

8.05%

-

8.05%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD USD 0.01

(UTM)

-

 

Below 5%

 

-

Below 5%

SUBTOTAL 8. A

 

Below 5%

 

Below 5%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Legal & General Group (Direct/Indirect)

5.26%

5.26%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

5.26%

5.26%

 

Legal & General Group (Direct)

Below 3%

Below 3%

 

Legal & General Assurance Society (Direct)

 

Below 3%

 

Below 3%

 

 

Legal & General Group (Direct/Indirect)

 

5.26%

 

5.26%

 

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

5.26%

5.26%

Legal & General Group (Direct)

Below 3%

Below 3%

Legal & General Assurance (Pensions Management) Limited

(Direct)

Below 3%

Below 3%

Legal & General Group (Direct/Indirect)

 

5.26%

 

5.26%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

5.26%

5.26%

Legal & General Group (Direct/Indirect)

 

5.26%

 

5.26%

Legal & General Investment Management Limited (Indirect)

5.26%

5.26%

Legal & General Group (Direct/Indirect)

 

5.26%

 

5.26%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

5.26%

5.26%

Legal & General (Unit Trust Managers) Limited (Indirect)

Below 5%

Below 5%

Legal & General Group (Direct/Indirect)

 

5.26%

 

5.26%

Legal & General Investment Management (Holdings) Limited

(Direct/Indirect)

5.26%

5.26%

Go ETF Solutions

Below 5%

Below 5%

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

 

 

 

 

 

 

11. Additional informationxvi

 

 

Notification using the total voting rights figure of 57,403,583

 

 

 

Place of completion

Brunel House, 2 Fitzalan Road, Cardiff, CF24 0EB

Date of completion

22/01/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLFLFIDLAIFFII
Date   Source Headline
11th Nov 20217:00 amRNSMaxCyte Reports Third Quarter Financial Results
3rd Nov 20211:00 pmRNSAppointment of Chairman of the Board
29th Oct 20215:01 pmRNSResult of AGM
28th Oct 20213:00 pmRNSLicense with Nkarta, Inc.
26th Oct 20217:00 amRNSNotice of Results
6th Oct 20217:00 amRNSHoldings in Company
1st Oct 20213:49 pmRNSNotice of AGM and Change of Director
1st Oct 202112:36 pmRNSTotal Voting Rights
17th Sep 20212:35 pmRNSMaxCyte Set to Join Russell 2000® Index
14th Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSFiling of Form 10-Q
2nd Sep 20212:26 pmRNSNotice of Results
10th Aug 20217:00 amRNSGrant of Options
9th Aug 20217:00 amRNSLicense with Sana Biotechnology
5th Aug 20214:05 pmRNSAmendments to Bylaws
3rd Aug 20213:51 pmRNSClosing of Offering
2nd Aug 20217:00 amRNSFull Exercise of Over-Allotment Option
30th Jul 20214:43 pmRNSSecond Price Monitoring Extn
30th Jul 20214:36 pmRNSPrice Monitoring Extension
30th Jul 20217:00 amRNSPricing of Offering and Approval to List on Nasdaq
26th Jul 202111:14 amRNSLaunch of Offering and Application to List
19th Jul 202112:30 pmRNSTermination of DI facility and transition to CDI
12th Jul 20217:00 amRNSS-1 Financial information & Directorate Change
12th Jul 20217:00 amRNSPublic Filing of Registration Statement with SEC
6th Jul 20215:36 pmRNSResult of Special Meeting
16th Jun 20217:01 amRNSPublication of Annual Report and Accounts
16th Jun 20217:00 amRNSStockholder Circular and Notice of Special Meeting
15th Jun 20217:00 amRNSMaxcyte Appoints Two New Non-Executive Directors
2nd Jun 20219:18 amRNSTotal Voting Rights
25th May 20217:00 amRNSSigning of Strategic Platform Licence
14th May 20217:00 amRNSProposed Dual-Listing on Nasdaq
13th May 20217:00 amRNSConsolidation of Trading Lines
20th Apr 20217:00 amRNSFull Year Results
15th Apr 20217:00 amRNSNotice of Full Year Results
1st Apr 20217:00 amRNSTotal Voting Rights
11th Mar 20213:01 pmRNSHolding(s) in Company
3rd Mar 20217:00 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSParticipation in Upcoming Investor Conferences
19th Feb 20217:00 amRNSDirector Dealings and Issue of Equity
17th Feb 20215:44 pmRNSGrant of Options
15th Feb 20214:32 pmRNSHolding(s) in Company
12th Feb 20211:59 pmRNSHolding(s) in Company
8th Feb 20212:59 pmRNSHolding(s) in Company
5th Feb 20219:01 amRNSPrice Monitoring Extension
4th Feb 20217:00 amRNSDirector Dealings and Issue of Equity
4th Feb 20217:00 amRNSCORRECTION: MaxCyte Announces £40m Subscription
3rd Feb 20214:36 pmRNSMaxCyte Announces £40 million Subscription
3rd Feb 20214:35 pmRNSAppointment of Joint Corporate Broker
21st Jan 20212:49 pmRNSIncrease to Block Listing
20th Jan 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.